558 related articles for article (PubMed ID: 7544357)
1. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
Welsh CF; Zhu D; Bourguignon LY
J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction.
Bourguignon LY; Lokeshwar VB; Chen X; Kerrick WG
J Immunol; 1993 Dec; 151(12):6634-44. PubMed ID: 7505012
[TBL] [Abstract][Full Text] [Related]
3. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
Zhu D; Bourguignon LY
Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion.
Zhu D; Bourguignon L
Oncogene; 1996 Jun; 12(11):2309-14. PubMed ID: 8649770
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells.
Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A
Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
Abetamann V; Kern HF; Elsässer HP
Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
[TBL] [Abstract][Full Text] [Related]
7. New CD44 splice variants associated with human breast cancers.
Iida N; Bourguignon LY
J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
[TBL] [Abstract][Full Text] [Related]
8. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells.
Bourguignon LY; Gunja-Smith Z; Iida N; Zhu HB; Young LJ; Muller WJ; Cardiff RD
J Cell Physiol; 1998 Jul; 176(1):206-15. PubMed ID: 9618160
[TBL] [Abstract][Full Text] [Related]
9. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
Bourguignon LY; Zhu H; Shao L; Zhu D; Chen YW
Cell Motil Cytoskeleton; 1999; 43(4):269-87. PubMed ID: 10423269
[TBL] [Abstract][Full Text] [Related]
10. Inducible binding of human lymphocytes to hyaluronate via CD44 does not require cytoskeleton association but does require new protein synthesis.
Murakami S; Shimabukuro Y; Miki Y; Saho T; Hino E; Kasai D; Nozaki T; Kusumoto Y; Okada H
J Immunol; 1994 Jan; 152(2):467-77. PubMed ID: 7506725
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 isoforms in human prostate tumor cell lines.
Stevens JW; Palechek PL; Griebling TL; Midura RJ; Rokhlin OW; Cohen MB
Prostate; 1996 Mar; 28(3):153-61. PubMed ID: 8628718
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
Lokeshwar BL; Lokeshwar VB; Block NL
Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
[TBL] [Abstract][Full Text] [Related]
14. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.
Harn HJ; Ho LI; Yu CP; Wang MW; Lee HS; Lin JJ; Lee WH; Isola NR; Cooper DL
Biochem Mol Biol Int; 1994 Feb; 32(2):233-8. PubMed ID: 7517252
[TBL] [Abstract][Full Text] [Related]
15. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
Zhu D; Bourguignon LY
J Cell Physiol; 2000 May; 183(2):182-95. PubMed ID: 10737894
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
[TBL] [Abstract][Full Text] [Related]
17. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
18. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
Wallach SB; Friedmann A; Naor D
Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
Uff CR; Neame SJ; Isacke CM
Eur J Immunol; 1995 Jul; 25(7):1883-7. PubMed ID: 7542594
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
